We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$22.6B
AUM Growth
+$4.98B
Cap. Flow
+$4.53B
Cap. Flow %
20.05%
Top 10 Hldgs %
40.91%
Holding
2,774
New
620
Increased
589
Reduced
714
Closed
789

Sector Composition

Rank Sector Weight
1 Technology 11.68%
2 Industrials 8.46%
3 Financials 6.56%
4 Consumer Discretionary 5.98%
5 Healthcare 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CABA icon
776
Cabaletta Bio
CABA
$450M
$2.64M 0.01%
1,204,070
+159,901
+15% +$396K
ANNX icon
777
Annexon
ANNX
$918M
$2.62M 0.01%
522,846
+310,627
+146% +$1.19M
GFL icon
778
GFL Environmental
GFL
$15B
$2.61M 0.01%
60,858
+56,260
+1,224% +$2.51M
STLA icon
779
Stellantis
STLA
$20.9B
$2.61M 0.01%
239,586
+204,829
+589% +$2.2M
EQNR icon
780
Equinor
EQNR
$93.7B
$2.6M 0.01%
+110,043
New +$2.59M
MATX icon
781
Matsons
MATX
$6.17B
$2.59M 0.01%
20,925
-2,820
-12% -$303K
GTY
782
Getty Realty Corp
GTY
$2.06B
$2.56M 0.01%
93,604
-363,932
-80% -$10.1M
GSHR
783
Gesher Acquisition Corp II
GSHR
$215M
$2.56M 0.01%
249,114
-87,886
-26% -$900K
BCSS.U
784
Bain Capital GSS Investment Corp Units
BCSS.U
$2.55M 0.01%
249,876
-150,124
-38% -$1.55M
BXBL
785
BOXABL, Inc. Common stock
BXBL
$1.51B
$2.55M 0.01%
254,099
+41,683
+20% +$418K
SZZL
786
Sizzle Acquisition Corp II
SZZL
$325M
$2.55M 0.01%
250,650
-54,421
-18% -$553K
MREO
787
Mereo BioPharma
MREO
$48.8M
$2.54M 0.01%
6,090,381
+4,357,657
+251% +$8.29M
OKLO
788
Oklo
OKLO
$7.34B
$2.53M 0.01%
35,247
+29,107
+474% +$3.25M
SAC.U
789
Safeguard Acquisition Corp Units
SAC.U
$2.52M 0.01%
+249,900
New +$2.52M
GIWWU
790
GigCapital8 Corp Units
GIWWU
$2.5M 0.01%
+244,559
New +$2.51M
RYN icon
791
Rayonier
RYN
$6.45B
$2.5M 0.01%
115,295
-91,446
-44% -$2.07M
MKLY
792
McKinley Acquisition Corp
MKLY
$249M
$2.49M 0.01%
+250,000
New +$2.49M
PFG icon
793
Principal Financial Group
PFG
$24.7B
$2.49M 0.01%
28,235
-115,019
-80% -$9.71M
NMRK icon
794
Newmark Group
NMRK
$2.66B
$2.48M 0.01%
143,305
-36,820
-20% -$645K
ABT icon
795
Abbott
ABT
$187B
$2.48M 0.01%
19,816
-6,058
-23% -$772K
PM icon
796
Philip Morris
PM
$293B
$2.46M 0.01%
15,310
-9,342
-38% -$1.45M
FBP icon
797
First Bancorp
FBP
$4.44B
$2.45M 0.01%
118,039
+40,961
+53% +$844K
DK icon
798
Delek US
DK
$3.59B
$2.44M 0.01%
82,362
+22,009
+36% +$786K
CMPX icon
799
Compass Therapeutics
CMPX
$358M
$2.43M 0.01%
452,442
-23,849
-5% -$110K
VSXY
800
Victoria's Secret
VSXY
$7.43B
$2.43M 0.01%
44,773
-66,362
-60% -$2.64M

Similar funds

Schonfeld Strategic Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Schonfeld Strategic Advisors held 2,774 positions worth $22.6B, up 28% from $17.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Schonfeld Strategic Advisors deployed $4.53B of net new capital in Q4 2025, opening 620 new positions and adding to 589 existing holdings. Its largest new stake was Medline Inc: 1,945,050 shares worth $81.7M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $213M trimmed.

  • Schonfeld Strategic Advisors's largest Q4 2025 buy was Medline Inc: 1,945,050 shares worth $81.7M.
  • Schonfeld Strategic Advisors added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $5.4B increase.
  • Schonfeld Strategic Advisors's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $213M.
  • Schonfeld Strategic Advisors fully exited Southwest Airlines in Q4 2025, selling an estimated $73.9M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 41% of its $22.6B portfolio in Q4 2025.
  • Schonfeld Strategic Advisors opened 620 new positions and closed 789 in Q4 2025.
  • Schonfeld Strategic Advisors's portfolio value rose 28% quarter-over-quarter to $22.6B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.